Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cefotetan MeSH Descriptor Data 2026


MeSH Heading
Cefotetan
Tree Number(s)
D02.065.589.099.249.250.199
D02.886.665.074.250.199
D03.383.129.617.235
D03.633.100.300.249.250.199
Unique ID
D015313
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015313
Scope Note
A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
Entry Term(s)
Apacef
Apatef
Cefotan
Cefotetan Disodium
Cefotetan Disodium Salt
Ceftotan
ICI-156834
YM-09330
Pharm Action
Anti-Bacterial Agents
Registry Numbers
48SPP0PA9Q
0
0GXP746VXB
Related Numbers
0GXP746VXB
69712-56-7
74356-00-6
CAS Type 1 Name
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha))-
Previous Indexing
Cephamycins (1982-1988)
Public MeSH Note
89
History Note
89
Date Introduced
1989/01/01
Last Updated
2017/05/24
Cefotetan Preferred
ICI-156834 Narrower
Ceftotan Narrower
Cefotetan Disodium Narrower
Apatef Narrower
Apacef Narrower
YM-09330 Narrower
page delivered in 0.158s